ES2086666T3 - Composiciones de activacion cerebral. - Google Patents

Composiciones de activacion cerebral.

Info

Publication number
ES2086666T3
ES2086666T3 ES92308053T ES92308053T ES2086666T3 ES 2086666 T3 ES2086666 T3 ES 2086666T3 ES 92308053 T ES92308053 T ES 92308053T ES 92308053 T ES92308053 T ES 92308053T ES 2086666 T3 ES2086666 T3 ES 2086666T3
Authority
ES
Spain
Prior art keywords
brain activation
brain
cerebral performance
activation compositions
alleviation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92308053T
Other languages
English (en)
Inventor
Joachim Bormann
Wolfgang Schatton
Rudiger Koch
Roman Gortelmeyer
Lothar Demisch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merz and Co GmbH and Co KG
Original Assignee
Merz and Co GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz and Co GmbH and Co KG filed Critical Merz and Co GmbH and Co KG
Application granted granted Critical
Publication of ES2086666T3 publication Critical patent/ES2086666T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

SE MUESTRA EL USO DE UNA CANTIDAD INHIBIDORA DE ACTIVASA MONOAMINA EFECTIVA O PORCION DE SUSTANCIA DE GROSELLA NEGRA (RIBES NIGRUM L.) O EXTRACTO SECO O CONCENTRADO CONSIGUIENTE PARA ACTIVAR EL CEREBRO Y EL SISTEMA NERVIOSO CENTRAL, EN UN SER VIVO, ESPECIALMENTE EN UN SER HUMANO, QUE LO NECESITA, Y POR TANTO INCREMENTAR EL FUNCIONAMIENTO CEREBRAL GENERAL, ESPECIALMENTE EN PERSONAS MAYORES Y SANAS, Y PARA PREVENCION, TRATAMIENTO Y ATENUACION DE ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON FUNCIONAMIENTO CEREBRAL REDUCIDO, COMO ENFERMEDAD DE PARKINSON, DEMENCIA O DESORDENES DEL CARACTER.
ES92308053T 1991-09-06 1992-09-04 Composiciones de activacion cerebral. Expired - Lifetime ES2086666T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/755,814 US5262162A (en) 1991-09-06 1991-09-06 Cerebral-activating extract

Publications (1)

Publication Number Publication Date
ES2086666T3 true ES2086666T3 (es) 1996-07-01

Family

ID=25040758

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92308053T Expired - Lifetime ES2086666T3 (es) 1991-09-06 1992-09-04 Composiciones de activacion cerebral.

Country Status (11)

Country Link
US (1) US5262162A (es)
EP (1) EP0531155B1 (es)
JP (1) JPH05194247A (es)
KR (1) KR100256452B1 (es)
AT (1) ATE135916T1 (es)
CA (1) CA2077589A1 (es)
DE (1) DE69209414T2 (es)
DK (1) DK0531155T3 (es)
ES (1) ES2086666T3 (es)
GR (1) GR3020121T3 (es)
TW (1) TW217989B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0743062B1 (de) * 1995-05-17 2001-08-16 Peter Greither Verfahren zum Herstellen eines Brausepräparats und Brausepräparat
US5747006A (en) * 1997-05-14 1998-05-05 Amway Corporation Skin whitener composition containing acerola cherry fermentate
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
US5866585A (en) * 1997-05-22 1999-02-02 Synchroneuron, Llc Methods of treating tardive dyskinesia using NMDA receptor antagonists
DE59706616D1 (de) * 1997-10-27 2002-04-18 Gergely Gerhard Brausezubereitung mit Pflanzenextrakt
US5952389A (en) * 1998-01-13 1999-09-14 Synchroneuron Methods of treating tardive dyskinesia and other movement disorders
US6294583B1 (en) 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
CA2319318A1 (en) * 1998-01-27 1999-07-29 Thomas N. Thomas Methods of treatment using mao-a and mao-b inhibitors such as l-deprenyl
US6184247B1 (en) 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
US6413558B1 (en) 1999-07-19 2002-07-02 The Proctor & Gamble Co. Compositions, kits, and methods for providing and maintaining energy and metal alertness
DE102004041270A1 (de) 2004-08-26 2006-03-02 Merz Pharma Gmbh & Co. Kgaa Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung
ES2538088T5 (es) * 2010-08-27 2019-04-17 Finzelberg Gmbh & Co Kg Extractos vegetales de Sideritis y su uso para el aumento de la capacidad cognitiva
AU2014292541B2 (en) 2013-07-14 2018-11-15 Asiros A/S Alkaloid compositions from ribes species to treat conditions assosiated with mitochondrial function or inhibition of PDE4, PDE5 and IKK-Beta
HUE051469T2 (hu) 2014-09-16 2021-03-01 Roar Holding Llc Energiaitalok és egyéb táplálkozási segédanyagok, amelyek agavé alapú szeszes italokból származnak
AU2018323787A1 (en) * 2017-08-28 2020-04-09 Vitality Wellness (Nz) Limited Improvements in IGF-1 analysis, adjustment and disease management of non-neurological and/or neurological conditions
JP2022511759A (ja) 2018-11-26 2022-02-01 ロアー ホールディング エルエルシー 飲料品質を改善する方法
US11839622B1 (en) 2020-01-15 2023-12-12 Randall Lewarchik Consumable nutraceutical composition
WO2023163606A1 (en) * 2022-02-28 2023-08-31 Arepa Ip Limited Bioactives and their uses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR92301E (fr) * 1963-08-09 1968-10-25 Chibret Lab Perfectionnements apportés aux procédés pour l'obtention de glucosides notamment de glucosides d'anthocyanes
FR6760M (es) * 1967-05-30 1969-03-03
EP0092076B1 (fr) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Composition lipidique destinée à l'alimentation orale, entérale ou parentérale
GB2147911B (en) * 1983-10-14 1987-10-07 Nestle Sa A process for the preparation of fatty substances
FR2583640A1 (fr) * 1985-06-24 1986-12-26 Berdal Pascal Compositions pharmaceutiques a visee vasculotrope et antisclereuse
GB2183635B (en) * 1985-10-11 1990-01-24 Peter Jowett Glyceride ester of gamma-linolenic acid
GB8714772D0 (en) * 1987-06-24 1987-07-29 Efamol Ltd Essential fatty acid compositions
FR2622453A1 (fr) * 1987-11-04 1989-05-05 Vaillant Defresne Laboratoire Composition sous forme de gel transparent contenant des grains ou des particules de plantes fraiches ou seches, son procede de preparation et utilisation en cosmetologie, en pharmacie et en hygiene

Also Published As

Publication number Publication date
EP0531155A1 (en) 1993-03-10
DE69209414D1 (de) 1996-05-02
EP0531155B1 (en) 1996-03-27
CA2077589A1 (en) 1993-03-07
JPH05194247A (ja) 1993-08-03
DK0531155T3 (da) 1996-06-10
GR3020121T3 (en) 1996-08-31
DE69209414T2 (de) 1996-12-05
US5262162A (en) 1993-11-16
KR100256452B1 (ko) 2000-05-15
ATE135916T1 (de) 1996-04-15
TW217989B (es) 1993-12-21

Similar Documents

Publication Publication Date Title
ES2086666T3 (es) Composiciones de activacion cerebral.
Barsky Amplification, somatization, and the somatoform disorders.
FI911986A0 (fi) Farmaceutiska foereningar.
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
ATE100322T1 (de) Verwendung von uridin zur behandlung nervoeser stoerungen.
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
SV1998000138A (es) Uso de aminometil-cromanos sustituidos para el impedimento de la degeneracion neuronal y para el estimulo de la regeneracion neuronal ref.lea 32408
EP0267676A3 (en) Use of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine in the treatment of cerebrovascular or cerebral senility associated disorders, peripheral vascular disease and proliferative skin diseases
Caplan Population-oriented psychiatry.
EP0383171A3 (en) 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
HUP9701606A2 (hu) Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására
DE69622005D1 (de) Zusammensetzung zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut und eine oder mehrere antimikrobielle Mitteln enthalten
PE37498A1 (es) Composiciones para la prevencion y tratamiento de trastornos gastrointestinales
MY113635A (en) Methods and compositions for the prevention and treatment of gastrointestinal disorders
ATE232736T1 (de) Zusammensetzungen zur vorbeugung und behandlung von urogenitalen störungen, die wismut enthalten
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
PE37398A1 (es) Composiciones para la prevencion y tratamiento de transtornos gastrointestinales
Bonnet et al. Contrasting changes of soleus-and gastrocnemius medialis stretch responses during preparation for arm movements in standing man
PE37198A1 (es) Composiciones para la prevencion y tratamiento de transtornos gastrointestinales
ECSP982751A (es) Uso de aminometil-cromanos sustituidos para el impedimento de la degeneracion neuronal y para el estimulo de la regeneracion neuronal

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 531155

Country of ref document: ES